Search Results Search Sort by RelevanceMost Recent Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777. Medicine and Society Jul 2017 Transcending the Tragedy Discourse of Dementia: An Ethical Imperative for Promoting Selfhood, Meaningful Relationships, and Well-Being Peter Reed, PhD, MPH, Jennifer Carson, PhD, and Zebbedia Gibb, PhD Authentic partnerships with people with dementia motivate full social participation and resist fatalism around experiences of illness. AMA J Ethics. 2017;19(7):693-703. doi: 10.1001/journalofethics.2017.19.7.msoc1-1707. Medicine and Society Jul 2017 Arts Participation: Counterbalancing Forces to the Social Stigma of a Dementia Diagnosis Beth Bienvenu, PhD and Gay Hanna, PhD, MFA Arts participation can counterbalance the social stigma of Alzheimer’s disease by fostering the autonomy and creativity of those with the diagnosis. AMA J Ethics. 2017;19(7):704-712. doi: 10.1001/journalofethics.2017.19.7.msoc2-1707. Medicine and Society Dec 2016 Manipulating Memories: The Ethics of Yesterday’s Science Fiction and Today’s Reality Julie M. Robillard, PhD and Judy Illes, PhD Neuromodulation has ethical implications for self-identity and public communication of scientific findings. AMA J Ethics. 2016;18(12):1225-1231. doi: 10.1001/journalofethics.2016.18.12.msoc1-1612. Medicine and Society Aug 2004 Presymptomatic Genetic Testing for Neurodegenerative Diseases Shane K. Green, PhD Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly. Virtual Mentor. 2004;6(8):360-363. doi: 10.1001/virtualmentor.2004.6.8.msoc1-0408.
Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777.
Medicine and Society Jul 2017 Transcending the Tragedy Discourse of Dementia: An Ethical Imperative for Promoting Selfhood, Meaningful Relationships, and Well-Being Peter Reed, PhD, MPH, Jennifer Carson, PhD, and Zebbedia Gibb, PhD Authentic partnerships with people with dementia motivate full social participation and resist fatalism around experiences of illness. AMA J Ethics. 2017;19(7):693-703. doi: 10.1001/journalofethics.2017.19.7.msoc1-1707.
Medicine and Society Jul 2017 Arts Participation: Counterbalancing Forces to the Social Stigma of a Dementia Diagnosis Beth Bienvenu, PhD and Gay Hanna, PhD, MFA Arts participation can counterbalance the social stigma of Alzheimer’s disease by fostering the autonomy and creativity of those with the diagnosis. AMA J Ethics. 2017;19(7):704-712. doi: 10.1001/journalofethics.2017.19.7.msoc2-1707.
Medicine and Society Dec 2016 Manipulating Memories: The Ethics of Yesterday’s Science Fiction and Today’s Reality Julie M. Robillard, PhD and Judy Illes, PhD Neuromodulation has ethical implications for self-identity and public communication of scientific findings. AMA J Ethics. 2016;18(12):1225-1231. doi: 10.1001/journalofethics.2016.18.12.msoc1-1612.
Medicine and Society Aug 2004 Presymptomatic Genetic Testing for Neurodegenerative Diseases Shane K. Green, PhD Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly. Virtual Mentor. 2004;6(8):360-363. doi: 10.1001/virtualmentor.2004.6.8.msoc1-0408.